# Clopidogrel to Prasugrel in Acute Coronary Syndrome (ACS) Patients

> **NCT01115738** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 282 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Prasugrel
- **DRUG:** Clopidogrel
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01115738
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 282 (ACTUAL)
- **Last updated:** 2012-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01115738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01115738, "Clopidogrel to Prasugrel in Acute Coronary Syndrome (ACS) Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01115738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*